New product Xtonic

An innovative Medical Device, patented, with European certification from Cermet.

Xtonic®, a combination of sodium chloride and D-mannitol, in an optimal ratio, has been specifically designed for the inhalator treatment of Cystic Fibrosis, Primary ciliary dyskinesia and Bronchiectasis.

The combination of two effective ingredients in an optimal dosage to achieve a better tolerability and efficacy compared to hypertonic saline or mannitol, alonextonic

Swiss Synergy Pharma is well-positioned to bring

cutting-edge solutions

TO THE MARKET

We are open for new partnerships

SYNERGY SWISS PHARMA

BUSINESS DEVELOPMENT

SYNERGY SWISS PHARMA

ENGINEERING

Synergy Swiss Pharma Sagl

Via Luigi Lavizzari 4, 6850 Mendrisio - Switzerland
+41 (0) 91 930 70 71

NEW OPENING

MALAYSIA

WITH DISTRIBUTION IN WHOLE ASIA FOR API AND FDF